NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Omics of Cancer: OncoGenomics

This study is NOT currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

000046-C

Sponsoring Institute

National Cancer Institute (NCI)

Recruitment Detail

Type: Recruitment has not started
Gender: Male & Female
Min Age: 4 wk
Max Age: N/A

Referral Letter Required

No

Population Exclusion(s)

None

Keywords

Oncogenomics;
Malignancies;
Therapeutic Strategies;
Human Genome Project;
Cancer;
Tumor Genome;
Natural History

Recruitment Keyword(s)

None

Condition(s)

Neoplasms;
Cancer

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Cancer Institute

Background:

Cancer is a leading cause of death in the United States. Researchers want to know more about how cancer develops and grows. They want to understand more about cancers that run in families. This information will help them find better ways to diagnose and treat cancer. Researchers need to collect data from many people who either have cancer or who may get cancer.

Objective:

To establish a registry of data about people with cancer. The natural history registry will be linked to a database with information about their genetics.

Eligibility:

People aged 4 weeks and older with a diagnosis of any cancer. People with precancerous conditions or with a family history of an inherited cancer are also needed.

Design:

Participants will answer questions about their medical history. This visit can be in-person or by phone.

Participants will provide blood and saliva samples. Researchers will also collect any samples the participants may already have given in the past. These may include tumor biopsies or samples of bone marrow or other body fluids. No blood will be collected from children younger than 3 years.

No new surgeries or biopsies will be done for this study.

The samples will be used for genetic research.

Researchers will follow up with participants once a year. They will get an updated medical history. They will ask for any new biopsies or other tissue samples. They may collect new saliva and blood samples.

Participants may continue in the study for the rest of their lives.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

-Age >= 4 weeks

-Participants must have:

--diagnosis of any tumor, malignancy, pre-malignant disorder

OR

--evidence of an inherited cancer syndrome based on family history and/or other manifestations of the syndrome (i.e., polyposis, plexiform neurofibromas, myelodysplastic syndrome)

-Participants must

--have biospecimen (e.g., tumor, normal, blood, bone marrow, serum, plasma, or any other specimen) that has been previously collected and is available for research analysis

OR

--be scheduled to undergo surgery or biopsy for routine patient care on another research or standard of care protocol

OR

--be willing to provide blood and/or saliva specimens. Note: does not apply to children < 3 years old

-The ability of participant or parent/guardian to understand and the willingness to sign a written consent document.

EXCLUSION CRITERIA:

None


--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

Javed Khan, M.D.
National Cancer Institute (NCI)
NIHBC 37 BG RM 2016B
37 CONVENT DR
BETHESDA MD 20892
(240) 760-6135
khanjav@mail.nih.gov

Chimene Kesserwan, M.D.
National Cancer Institute (NCI)
NIHBC 37 BG RM 6002
37 CONVENT DR
BETHESDA MD 20892
(301) 222-3925
chimene.kesserwan@nih.gov

NCI Referral Office
National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office
1-888-NCI-1937

Clinical Trials Number:

NCT05431439

--Back to Top--